Overexpression of miR-126 in primary CD4+ T cells from SLE patients contributed to T cell autoreactivity by targeting DNMT1, while inhibition in SLE patients resulted in T and B cell inactivation. This evidence concerns the gene CD4 and systemic lupus erythematosus.